A Japanese venture-led team has successfully bred three genetically modified pigs for use in human organ and cell transplants for the first time in Japan, which is struggling with donor shortages, the company said Tuesday.But the safety of such cross-species transplantation will be investigated with further animal testing for the time being, said the venture called PorMedTec Co. that was launched based on the research of the Meiji University International Institute for Bio-Resource Research.The team including members from U.S. biotechnology company eGenesis bred the pigs, born Sunday, using…READ FULL ARTICLE